The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland

Germline BRCA1 mutations increase prostate cancer risk

(2012) D Leongamornlert et al.   BRITISH JOURNAL OF CANCER

Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer

(2012) J. P. Breyer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk

(2012) Robert Karlsson et al.   EUROPEAN UROLOGY

Association Between Germline HOXB13 G84E Mutation and Risk of Prostate Cancer

(2012) M. R. Akbari et al.   JNCI-Journal of the National Cancer Institute

Germline Mutations inHOXB13and Prostate-Cancer Risk

(2012) Charles M. Ewing et al.   NEW ENGLAND JOURNAL OF MEDICINE

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

(2011) Z Kote-Jarai et al.   BRITISH JOURNAL OF CANCER

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

(2010) Anita V. Mitra et al.   BJU INTERNATIONAL